Liability Risk and Insurance
Sulzer settlement poised on brink
The 15 May opt-out deadline saw 132 patients refuse the court-approved terms of a US$1bn settlement deal. The purpose is to
settle claims from US patients arising from faulty hip and knee joints supplied by Sulzer Medica, but the number of opt-outs
are causing Sulzer to hesitate.